findmyKOL

Mayer Rashtian, MD

Basic profile

Huntington Hospital

ORCID↗NPI↗
✓ Full record
RegionPasadena, CA · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mayer Rashtian is a Cardiology physician affiliated with Huntington Hospital. OpenAlex indexes 38 publications with 2,148 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
38publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,148citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
55companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

625 S Fair Oaks Ave
Suite 215
Pasadena, CA 911052615

Telephone

626-793-4139

Provider last certified this registry record 27 Feb 2020.

View the NPPES registry record

Industry payments

55 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.5%
    Antiarrhythmic17.5%
    Amiodarone Hcl48%Flecainide Acetate38%Multaq14%
    Part D≥294 patients
    Beta blocker10.9%
    Carvedilol66%Metoprolol Succinate23%Nadolol4%Metoprolol Tartrate4%Sotalol3%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    39.6%
    Factor Xa inhibitor38.6%
    Eliquis54%Xarelto46%
    Part D≥544 patients
    P2Y12 inhibitor0.8%
    Clopidogrel100%
    Part D≥43 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    6.5%
    SGLT2 inhibitor5.6%
    Farxiga63%Jardiance31%Inpefa7%
    Part D≥84 patients
    Proton pump inhibitor0.4%
    Pantoprazole Sodium100%
    Part D≥34 patients

    + 2 more classes in this area

Where care is delivered (Part B)16.4% facility · 83.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”